SCHEMBL3666751

SCHEMBL3666751

CCCC[C@@H](B(O)O)N(C(=O)OCc1ccccc1)C(=O)[C@@H](N)CC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.40
PSMB5 P28074 5/20 0.39
ANPEP P15144 1/20 0.38
RNPEP Q9H4A4 1/20 0.38
DNPEP Q9ULA0 1/20 0.38
LNPEP Q9UIQ6 2/20 0.38
ERAP2 Q6P179 1/20 0.38
PSMB11 A5LHX3 1/20 0.38
PSMA7 O14818 1/20 0.38
PSMB1 P20618 1/20 0.38
PSMA1 P25786 1/20 0.38
PSMA2 P25787 1/20 0.38
PSMA3 P25788 1/20 0.38
PSMA4 P25789 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB9 P28065 1/20 0.38
PSMA5 P28066 1/20 0.38
PSMB4 P28070 1/20 0.38
PSMB6 P28072 1/20 0.38
PSMB10 P40306 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3660974 0.89 ANPEP (0.44) CTSKPSMB5ANPEPRNPEPDNPEP
SCHEMBL8744670 0.85 SLC1A3 (0.41) CTSKANPEPRNPEPDNPEPLNPEP
SCHEMBL3667251 0.84 CTSK (0.42) CTSKLNPEPERAP2CTSLCTSS
SCHEMBL27809385 0.78 ANPEP (0.48) CTSKANPEPRNPEPDNPEPCTSL
SCHEMBL7420644 0.77 ANPEP (0.43) CTSKANPEPRNPEPDNPEPCTSL
SCHEMBL8586811 0.77 CTSB (0.47) CTSKPSMB5ANPEPRNPEPDNPEP
SCHEMBL9023544 0.76 SLC15A1 (0.45) CTSKPSMB5PSMB11PSMA7PSMB1
SCHEMBL724023 0.76 CTSK (0.44) CTSKANPEPRNPEPDNPEPCTSL
SCHEMBL1014662 0.76 CTSB (0.44) CTSKPSMB5ANPEPRNPEPDNPEP
SCHEMBL27799677 0.75 ANPEP (0.45) CTSKANPEPRNPEPDNPEPCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234600-A1 ANTIBODY FORMULATION F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009080541-A1 ANTIBODY FORMULATION F. HOFFMANN-LA ROCHE AG (CH) 2009-07-02 WO disclosed